Roche Holding Ltd. Stock Swiss Exchange
Stocks
CH0012032048
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Swiss Exchange
|
||
| - CHF | - |
|
| 09-03 | Hutchmed Enters Licensing Agreement With GSK for Cancer Drug | DJ |
| 09-02 | Roche, Treeline Biosciences to Evaluate Combination Therapy for B-cell Lymphomas | MT |
| Market Cap | 285B 352B 303B 260B 487B 33,313B 489B 3,370B 1,308B 17,059B 1,324B 1,295B 55,032B | P/E 2026 * |
19.9x | P/E 2027 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise Value | 296B 365B 315B 270B 506B 34,582B 507B 3,499B 1,358B 17,709B 1,374B 1,344B 57,129B | EV / Sales 2026 * |
4.73x | EV / Sales 2027 * | 4.42x |
| Free-Float |
88.78% | Yield 2026 * |
2.8% | Yield 2027 * | 2.86% |
Last Transcript : Roche Holding Ltd.
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2023-03-14 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 2011-06-05 |
| Chief Operating Officer | - | 2025-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 1995-12-31 |
Severin Schwan
CHM | Chairman | 59 | 2023-03-14 |
| Director/Board Member | 73 | 2015-03-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.88% | -2.15% | +58.05% | +105.91% | 1,024B | |
| -1.15% | +2.68% | +54.25% | +71.29% | 663B | |
| -1.44% | +0.38% | +20.65% | +75.54% | 453B | |
| +0.14% | -0.47% | +29.49% | +38.56% | 352B | |
| -1.33% | +4.72% | +24.69% | +45.55% | 304B | |
| -1.15% | +0.30% | -1.49% | +12.31% | 252B | |
| -1.55% | +1.11% | +54.15% | +72.13% | 236B | |
| -0.88% | +1.15% | -17.09% | -54.39% | 206B | |
| -0.15% | +3.65% | +31.24% | +100.90% | 187B | |
| Average | -0.93% | +1.09% | +28.22% | +51.98% | 408.71B | |
| Weighted average by Cap. | -0.96% | +0.55% | +37.37% | +66.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.61B 77.28B 66.55B 57.14B 107B 7,313B 107B 740B 287B 3,745B 291B 284B 12,081B | 65.43B 80.75B 69.54B 59.71B 112B 7,642B 112B 773B 300B 3,914B 304B 297B 12,625B |
| Net income | 14.5B 17.89B 15.41B 13.23B 24.76B 1,693B 24.85B 171B 66.49B 867B 67.28B 65.81B 2,797B | 16.32B 20.14B 17.34B 14.89B 27.87B 1,906B 27.97B 193B 74.85B 976B 75.73B 74.08B 3,148B |
| Net Debt | 10.87B 13.41B 11.55B 9.92B 18.56B 1,269B 18.62B 128B 49.84B 650B 50.43B 49.33B 2,097B | 4.02B 4.96B 4.27B 3.67B 6.87B 469B 6.89B 47.5B 18.44B 240B 18.66B 18.25B 776B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
